Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Диагностика и лечение метаболического синдрома
Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, John A. Spertus, Fernando Costa
2005-09-13

atherogenic dyslipidemiaatherosclerotic cardiovascular diseasediagnostic criteriametabolic syndrometype 2 diabetes mellitus
The metabolic syndrome has received increased attention in the past few years. This statement from the American Heart Association (AHA) and the National Heart, Lung, and Blood Institute (NHLBI) is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults. The metabolic syndrome is a constellation of interrelated risk factors of metabolic origin— metabolic risk factors —that appear to directly promote the development of atherosclerotic cardiovascular disease (ASCVD).1 Patients with the metabolic syndrome also are at increased risk for developing type 2 diabetes mellitus. Another set of conditions, the underlying risk factors , give rise to the metabolic risk factors. In the past few years, several expert groups have attempted to set forth simple diagnostic criteria to be used in clinical practice to identify patients who manifest the multiple components of the metabolic syndrome. These criteria have varied somewhat in specific elements, but in general they include a combination of both underlying and metabolic risk factors. The most widely recognized of the metabolic risk factors are atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose. Individuals with these characteristics commonly manifest a prothrombotic state and a pro-inflammatory state as well. Atherogenic dyslipidemia consists of an aggregation of lipoprotein abnormalities including elevated serum triglyceride and apolipoprotein B (apoB), increased small LDL particles, and a reduced level of HDL cholesterol (HDL-C). The metabolic syndrome is often referred to as if it were a discrete entity with a single cause. Available data suggest that it truly is a syndrome, ie, a grouping of ASCVD risk factors, but one that probably has more than one cause. Regardless of cause, the syndrome identifies individuals at an elevated risk for ASCVD. The magnitude of the increased risk can vary according to which components of the syndrome are …
1
Atherogenic dyslipidemia includes elevated triglycerides and apolipoprotein B, increased small LDL particles, and reduced HDL cholesterol.
2
Core metabolic risk factors include atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose, often accompanied by prothrombotic and pro-inflammatory states.
3
Metabolic syndrome comprises interrelated metabolic risk factors that directly promote atherosclerotic cardiovascular disease and increase type 2 diabetes risk.
4
Metabolic syndrome is a heterogeneous clustering of cardiovascular risk factors with likely multiple underlying causes; its ASCVD risk varies according to component combinations.
5
The AHA/NHLBI statement provides updated guidance for diagnosing and managing metabolic syndrome in adults.

The metabolic syndrome in adults

its diagnosis, management, and associated risk factors for ASCVD and type 2 diabetes mellitus

Publication Details
Publication Date
2005-09-13
Journal
Circulation
Publisher
Lippincott Williams & Wilkins
ISSN
0009-7322
Cited by
13578
Access Type
Author Information
Authors
Scott M. Grundy
James I. Cleeman
Stephen R. Daniels
Karen A. Donato
Robert H. Eckel
Barry A. Franklin
David J. Gordon
Ronald M. Krauss
Peter J. Savage
Sidney C. Smith
John A. Spertus
Fernando Costa
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%